BV is common, highly recurrent, and associated with serious health risks and reproductive morbidity if left untreated.2
Different patients.
One effective solution.
Help ensure patients' adherence in treating BV with an effective single-dose oral regimen.1
Take the BV Challenge
Test your knowledge of BV epidemiology and clinical management principles with our challenge.
Secnidazole 2 g single dose treatment delivers standard-of-care efficacy.3
Untreated or improperly treated BV can contribute to recurrence and serious health consequences.2,4
SOLOSEC is included in 2021 CDC and 2020 ACOG guidelines for BV.2,5
BV is common, highly recurrent, and associated with serious health risks and reproductive morbidity if left untreated.2
Different patients. One effective solution.


Help ensure patients' adherence in treating BV with an effective single-dose oral regimen.1
Secnidazole 2 g single dose treatment delivers standard-of-care efficacy.3
Untreated or improperly treated BV can contribute to recurrence and serious health consequences.2,4
SOLOSEC is included in 2021 CDC and 2020 ACOG guidelines for BV.2,5
Take the BV Challenge
Test your knowledge of BV epidemiology and clinical management principles with our challenge.
References:
References: 1. SOLOSEC [prescribing information]. Baltimore, MD: Lupin Pharmaceuticals, Inc; 2021. 2. Workowski KA, Bachmann LH, Chan PA, et al. CDC Sexually Transmitted Diseases Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(RR-04):1-192. 3. Muzny CA, Schwebke JR, Nyirjesy P, et al. Efficacy and Safety of Single Oral Dosing of Secnidazole for Trichomoniasis in Women: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Delayed-Treatment Study. Clin Infect Dis 2021. 4. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin: Clinical Management Guidelines for Obstetricians-Gynecologists, Number 215. Obstet Gynecol 2020:135(1):e1-e17.